Tue, 05/02/2023 - 12:00 Publications Étude Fièvre Jaune Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial Share Share on Facebook Share on Telegram Share on LinkedIn Share on Twitter Copy link Page url is copied Read on Lancet Infectious Diseases Newsroom Read more 05 Jul 2024 Vidéos Officially launching of Antibiogo : Webinar 02 Jul 2024 Vidéos Report from Adre in Chad, where MSF Foundation teams explore the needs for pediatric rehabilitation. 08 Apr 2024 Vidéos Reportage in Haydan, Yemen, on the development of the rehabilitation care in the MSF sites.
02 Jul 2024 Vidéos Report from Adre in Chad, where MSF Foundation teams explore the needs for pediatric rehabilitation.
08 Apr 2024 Vidéos Reportage in Haydan, Yemen, on the development of the rehabilitation care in the MSF sites.
